<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=799546403794687&amp;ev=PageView&amp;noscript=1">

Low MELD Score No Barrier to Long Survival After Living-Donor Transplant

minute read.

Written by MedPage Today on August 3, 2022

End-stage liver disease patients at lower risk for death in the short term still reaped the substantial benefits of a living-donor liver transplant (LDLT), a case-control study revealed.

Topics: Press Coverage